S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 361 to 420 of 527

Issue Date	Title / Author(s) / Citation	File
2017-04	First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors Bang, Y. J.; Giaccone, G.; Im, S. A.; Oh, D. Y.; Bauer, T. M.; Nordstrom, J. L.; Li, H.; Chichili, G. R.; Moore, P. A.; Hong, S.; Stewart, S. J.; Baughman, J. E.; Lechleider, R. J.; Burris, H. A. Annals of Oncology, Vol.28 No.4, pp.855-861	DOI
2017-04	AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Kim, Seongyeong; Lee, Miso; Kim, Debora Keunyoung; Yang, Yaewon; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Jin Won; Kim, Tae-Yong; Oh, Do-Youn; Brown, Jeff; Lau, Alan; O'Connor, Mark J.; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.16 No.4, pp.566-577	DOI
2017-04	Phosphorylated Akt expression as a favorable prognostic factor for patients undergoing curative resection and adjuvant chemoradiotherapy for proximal extrahepatic bile duct cancer Kim, Byoung Hyuck; Kim, Kyubo; Min, Hye Sook; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Jang, Ja-June; Ha, Sung W. American Journal of Clinical Oncology, Vol.40 No.2, pp.158-162	DOI
2017-05	Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial Twelves, Chris; Cortes, Javier; O'Shaughnessy, Joyce; Awada, Ahmad; Perez, Edith A.; Im, Seock-Ah; Gomez-Pardo, Patricia; Schwartzberg, Lee S.; Dieras, Veronique; Yardley, Denise A.; Potter, David A.; Mailliez, Audrey; Moreno-Aspitia, Alvaro; Ahn, Jin-Seok; Zhao, Carol; Hoch, Ute; Tagliaferri, Mary; Hannah, Alison L.; Rugo, Hope S. European Journal of Cancer, Vol.76, pp.205-215	DOI
2017-05	Late chronotypes are associated with neoadjuvant chemotherapy-induced nausea and vomiting in women with breast cancer Lee, Kwang-Min; Jung, Doo-Young; Hwang, Heesung; Kim, Won-Hyoung; Lee, Joo-Young; Kim, Tae-Yong; Im, Seock-Ah; Lee, Kyung-Hun; Spiegel, David; Hahm, Bong-Jin Chronobiology International, Vol.34 No.4, pp.480-491	DOI
2017-06	Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach Kurokawa, Yukinori; Yang, Han-Kwang; Cho, Haruhiko; Ryu, Min-Hee; Masuzawa, Toru; Park, Sook Ryun; Matsumoto, Sohei; Lee, Hyuk-Joon; Honda, Hiroshi; Kwon, Oh Kyoung; Ishikawa, Takashi; Lee, Kyung Hee; Nabeshima, Kazuhito; Kong, Seong-Ho; Shimokawa, Toshio; Yook, Jeong-Hwan; Doki, Yuichiro; Im, Seock-Ah; Hirota, Seiichi; Hahn, Seokyung; Nishida, Toshirou; Kang, Yoon-Koo British Journal of Cancer, Vol.117 No.1, pp.25-32	DOI
2017-06	Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy Masuda, N.; Lee, S. -J.; Ohtani, S.; Im, Y. -H.; Lee, E. -S.; Yokota, I.; Kuroi, K.; Im, S. -A.; Park, B. -W.; Kim, S. -B.; Yanagita, Y.; Ohno, S.; Takao, S.; Aogi, K.; Iwata, H.; Jeong, J.; Kim, A.; Park, K. -H.; Sasano, H.; Ohashi, Y.; Toi, M. New England Journal of Medicine, Vol.376 No.22, pp.2147-2159	DOI
2017-07	Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer Song, Su Jeong; Min, Ji; Suh, Sung Yun; Jung, Sun Hoi; Hahn, Hyeon Joo; Im, Seock-Ah; Lee, Ju-Yeun Supportive Care in Cancer, Vol.25 No.7, pp.2241-2248	DOI
2017-07	Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial Baselga, Jose; Im, Seock Ah; Iwata, Hiroji; Cortes, Javier; De laurentiis, Michele; Jiang, Zefei; Arteaga, Carlos L.; Jonat, Walter; Clemons, Mark; Ito, Yoshinori; Awada, Ahmad; Chia, Stephen; Jagiello-Gruszfeld, Agnieszka; Pistilli, Barbara; Tseng, Ling-Ming; Hurvitz, Sara; Masuda, Norikazu; Takahashi, Masato; Vuylsteke, Peter; Hachemi, Soulef; Dharan, Bharani; Di Tomaso, Emmanuelle; Urban, Patrick; Massacesi, Cristian; Campone, Mario The Lancet Oncology, Vol.18 No.7, pp.904-916	DOI
2017-07	Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis Kim, Seongyeong; Min, Ahrum; Lee, Kyung-Hun; Yang, Yaewon; Kim, Tae-Yong; Lim, Jee Min; Park, So Jung; Nam, Hyun-Jin; Kim, Jung Eun; Song, Sang-Hyun; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae-You; Hangauer, David; Lau, Johnson Yiu-Nam; Im, Kyongok; Lee, Dong Soon; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.3, pp.643-655	DOI
2017-07	CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy Lee, Dae-Won; Im, Seock-Ah; Kim, Yu Jung; Yang, Yaewon; Rhee, Jiyoung; Na, Im Ii; Lee, Kyung-Hun; Kim, Tae -Yong; Han, Sae -Won; Choi, In Sil; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae -You; Bang, Yung-Jue Cancer Research and Treatment, Vol.49 No.3, pp.807-815	DOI
2017-08	Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation Robson, Mark; Im, Seock-Ah; Senkus, Elzbieta; Xu, Binghe; Domchek, Susan M.; Masuda, Norikazu; Delaloge, Suzette; Li, Wei; Tung, Nadine; Armstrong, Anne; Wu, Wenting; Goessl, Carsten; Runswick, Sarah; Conte, Pierfranco New England Journal of Medicine, Vol.377 No.6, pp.523-533	DOI
2017-08	PALOMA-3: Phase III Trial of Fulvestrant With or Without Palbociclib in Premenopausal and Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Progressed on Prior Endocrine Therapy-Safety and Efficacy in Asian Patients Iwata, Hiroji; Im, Seock-Ah; Masuda, Norikazu; Im, Young-Hyuck; Inoue, Kenichi; Rai, Yoshiaki; Nakamura, Rikiya; Kim, Jee Hyun; Hoffman, Justin T.; Zhang, Ke; Giorgetti, Carla; Lyer, Shrividya; Schnell, Patrick T.; Bartlett, Cynthia Huang; Ro, Jungsil Journal of Global Oncology, Vol.3 No.4, pp.289-303	DOI
2017-08	Mechanism of acquired resistance to lapatinib via Src and RUNX3 in breast cancer 김소현	view file
2017-09	EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release Suh, Koung Jin; Sung, Ji Hea; Kim, Jin Won; Han, Song-Hee; Lee, Hye Seung; Min, Ahrum; Kang, Mi Hyun; Kim, Ji Eun; Kim, Ji-Won; Kim, Se Hyun; Lee, Jeong-Ok; Kim, Yu Jung; Lee, Keun-Wook; Kim, Jee Hyun; Bang, Soo-Mee; Im, Seock-Ah; Lee, Jong Seok Oncotarget, Vol.8 No.38, pp.63901-63910	DOI
2017-09	Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial Cortes, Javier; Rugo, Hope S.; Awada, Ahmad; Twelves, Chris; Perez, Edith A.; Im, Seock-Ah; Gomez-Pardo, Patricia; Schwartzberg, Lee S.; Dieras, Veronique; Yardley, Denise A.; Potter, David A.; Mailliez, Audrey; Moreno-Aspitia, Alvaro; Ahn, Jin-Seok; Zhao, Carol; Hoch, Ute; Tagliaferri, Mary; Hannah, Alison L.; O'Shaughnessy, Joyce Breast Cancer Research and Treatment, Vol.165 No.2, pp.329-341	DOI
2017-09	Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results Loibl, Sibylle; Turner, Nicholas C.; Ro, Jungsil; Cristofanilli, Massimo; Iwata, Hiroji; Im, Seock-Ah; Masuda, Norikazu; Loi, Sherene; Andre, Fabrice; Harbeck, Nadia; Verma, Sunil; Folkerd, Elizabeth; Theall, Kathy Puyana; Hoffman, Justin; Zhang, Ke; Bartlett, Cynthia Huang; Dowsett, Mitchell Oncologist, Vol.22 No.9, pp.1028-1038	DOI
2017-09	Randomized Phase III Trial of Trastuzumab Plus Capecitabine With or Without Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Who Experienced Disease Progression During or After Trastuzumab-Based Therapy Urruticoechea, Ander; Rizwanullah, Mohammed; Im, Seock-Ah; Sanchez Ruiz, Antonio Carlos; Lang, Istvan; Tomasello, Gianluca; Douthwaite, Hannah; Crnjevic, Tanja Badovinac; Heeson, Sarah; Eng-Wong, Jennifer; Munoz, Montserrat Journal of Clinical Oncology, Vol.35 No.26, pp.3030-3038	DOI
2017-09	Human Epidermal Growth Factor Receptor 2 Expression in Unresectable Gastric Cancers: Relationship with CT Characteristics Lee, Jeong Sub; Kim, Se Hyung; Im, Seock-Ah; Kim, Min A.; Han, Joon Koo Korean Journal of Radiology, Vol.18 No.5, pp.809-820	DOI
2017-10	Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial Kim, Sung-Bae; Dent, Rebecca; Im, Seock-Ah; Espie, Marc; Blau, Sibel; Tan, Antoinette R.; Isakoff, Steven J.; Oliveira, Mafalda; Saura, Cristina; Wongchenko, Matthew J.; Kapp, Amy V.; Chan, Wai Y.; Singel, Stina M.; Maslyar, Daniel J.; Baselga, Jose The Lancet Oncology, Vol.18 No.10, pp.1360-1372	DOI
2017-10	Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors Suh, Koung Jin; Kim, Se Hyun; Lee, Kyung-Hun; Kim, Tae-Yong; Kim, Yu Jung; Han, Sae-Won; Kang, Eunyoung; Kim, Eun-Kyu; Kim, Kidong; No, Jae Hong; Han, Wonshik; Noh, Dong-Young; Lee, Maria; Kim, Hee Seung; Im, Seock-Ah; Kim, Jee Hyun Cancer Research and Treatment, Vol.49 No.4, pp.1153-1163	DOI
2017-10	Korean Cancer Patients' Awareness of Clinical Trials, Perceptions on the Benefit and Willingness to Participate Lim, Yoojoo; Lim, Jee Min; Jeong, Won Jae; Lee, Kyung-Hun; Keam, Bhumsuk; Kim, Tae-Yong; Kim, Tae Min; Han, Sae-Won; Oh, Do Youn; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.4, pp.1033-1043	view file DOI
2017-10	Skeletal muscle depletion predicts survival of patients with advanced biliary tract cancer undergoing palliative chemotherapy Cho, Kyoung-Min; Park, Hyunkyung; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncotarget, Vol.8 No.45, pp.79441-79452	DOI
2017-11	Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer Park, Yeon Hee; Im, Seock-Ah; Kim, Sung-Bae; Sohn, Joo Hyuk; Lee, Keun Seok; Chae, Yee Soo; Lee, Ki Hyeong; Kim, Jee Hyun; Im, Young-Hyuck; Kim, Ji-Yeon; Kim, Tae-Yong; Lee, Kyung-Hun; Ahn, Jin-Hee; Kim, Gun Min; Park, In Hae; Lee, Soo Jung; Han, Hye Sook; Kim, Se Hyun; Jung, Kyung Hae; Korean Cancer Study Group (KCSG) European Journal of Cancer, Vol.86, pp.385-393	DOI
2017-12	The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies Cortes, Javier; Im, Seock-Ah; Holgado, Esther; Perez-Garcia, Jose M.; Schmid, Peter; Chavez-MacGregor, Mariana Cancer Treatment Reviews, Vol.61, pp.53-60	DOI
2017-12	Cyclophosphamide, Methotrexate, and 5-Fluorouracil as Palliative Treatment for Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Retrospective Analysis Park, Jin Hyun; Im, Seock-Ah; Byun, Ja Min; Kim, Ki Hwan; Kim, Jin-Soo; Choi, In Sil; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do Youn; Kim, Tae-You Journal of Breast Cancer, Vol.20 No.4, pp.347-355	DOI
2017-12	Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial Bang, Yung-Jue; Xu, Rui-Hua; Chin, Keisho; Lee, Keun-Wook; Park, Se Hoon; Rha, Sun Young; Shen, Lin; Qin, Shukui; Xu, Nong; Im, Seock-Ah; Locker, Gershon; Rowe, Phil; Shi, Xiaojin; Hodgson, Darren; Liu, Yu-Zhen; Boku, Narikazu The Lancet Oncology, Vol.18 No.12, pp.1637-1651	DOI
2017-12	Treatment Patterns and Outcomes in Elderly Patients with Metastatic Breast Cancer: A Multicenter Retrospective Study Park, Jin Hyun; Choi, In Sil; Kim, Ki Hwan; Kim, Jin-Soo; Lee, Kyung-Hun; Kim, Tae-Yong; Im, Seock Ah; Kim, Se Hyun; Kim, Yu Jung; Kim, Jee Hyun Journal of Breast Cancer, Vol.20 No.4, pp.368-377	DOI
2017-12	Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline Sohn, Byeong Seok; Kim, Sung-Bae; Ahn, Jin-Hee; Jung, Kyung Hae; Kim, Jeongeun; Lee, Keun Seok; Ro, Jungsil; Im, Seock Ah; Im, Young-Hyuck; Song, Hong Suk; Park, Hee Sook; Chung, Hyun-Cheol Asia-Pacific Journal of Clinical Oncology, Vol.13 No.6, pp.365-371	DOI
2017-12	Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial ExteNET Study Group; Im, Seock Ah The Lancet Oncology, Vol.18 No.12, pp.1688-1700	DOI
2018-03	Phase III, Randomized study of dual human epidermal growth factor receptor 2 (HER2) blockade with lapatinib plus trastuzumab in combination with an aromatase inhibitor in postmenopausal women with HER2-positive, hormone receptor-positive metastatic breast cancer: ALTERNATIVE Johnston, Stephen R. D.; Hegg, Roberto; Im, Seock-Ah; Park, In Hae; Burdaeva, Olga; Kurteva, Galina; Press, Michael F.; Tjulandin, Sergei; Iwata, Hiroji; Simon, Sergio D.; Kenny, Sarah; Sarp, Severine; Izquierdo, Miguel A.; Williams, Lisa S.; Gradishar, William J. Journal of Clinical Oncology, Vol.36 No.8, pp.741-748	DOI
2018-03	Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases Turner, N. C.; Finn, R. S.; Martin, M.; Im, S. -A; DeMichele, A.; Ettl, J.; Dieras, V.; Moulder, S.; Lipatov, O.; Colleoni, M.; Cristofanilli, M.; Lu, D. R.; Mori, A.; Giorgetti, C.; Iyer, S.; Bartlett, C. Huang; Gelmon, K. A. Annals of Oncology, Vol.29 No.3, pp.669-680	DOI
2018-03	Integrated 18F-FDG PET/MRI in breast cancer: Early prediction of response to neoadjuvant chemotherapy Cho, Nariya; Im, Seock-Ah; Cheon, Gi Jeong; Park, In-Ae; Lee, Kyung-Hun; Kim, Tae-Yong; Kim, Young Seon; Kwon, Bo Ra; Lee, Jung Min; Suh, Hoon Young; Suh, Koung Jin European Journal of Nuclear Medicine and Molecular Imaging, Vol.45 No.3, pp.328-339	DOI
2018-03	A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma Lee, Dae-Won; Lee, Kyung-Hun; Kim, Hee-Jun; Kim, Tae-Yong; Kim, Jin-Soo; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Kim, Tae-You BMC Cancer, Vol.18 No.1, p. 252	DOI
2018-04	A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results Pivot, X.; Bondarenko, I.; Nowecki, Z.; Dvorkin, M.; Trishkina, E.; Ahn, J. H.; Im, S. A.; Sarosiek, T.; Chatterjee, S.; Wojtukiewicz, M. Z.; Shparyk, Y.; Moiseyenko, V.; Bello, M., III; Semiglazov, V.; Lee, Y.; Lim, J. European Journal of Cancer, Vol.93, pp.19-27	DOI
2018-04	Phase III, randomized, double-blind study comparing the efficacy, safety, and immunogenicity of SB3 (trastuzumab biosimilar) and reference trastuzumab in patients treated with neoadjuvant therapy for human epidermal growth factor receptor 2-positive early breast cancer Pivot, Xavier; Bondarenko, Igor; Nowecki, Zbigniew; Dvorkin, Mikhail; Trishkina, Ekaterina; Ahn, Jin-Hee; Vinnyk, Yuriy; Im, Seock-Ah; Sarosiek, Tomasz; Chatterjee, Sanjoy; Wojtukiewicz, Marek Z.; Moiseyenko, Vladimir; Shparyk, Yaroslav; Bello, Maximino, III; Semiglazov, Vladimir; Song, Sujeong; Lim, Jaeyun Journal of Clinical Oncology, Vol.36 No.10, pp.968-974	DOI
2018-04	Profiling of protein-protein interactions via single-molecule techniques predicts the dependence of cancers on growth-factor receptors Lee, Hong-Won; Choi, Byoungsan; Kang, Han Na; Kim, Hyunwoo; Min, Ahrum; Cha, Minkwon; Ryu, Ji Young; Park, Sangwoo; Sohn, Jinyoung; Shin, Kihyuk; Yun, Mi Ran; Han, Joo Yeun; Shon, Min Ju; Jeong, Cherlhyun; Chung, Junho; Lee, Seung-Hyo; Im, Seock-Ah; Cho, Byoung Chul; Yoon, Tae-Young Nature Biomedical Engineering, Vol.2 No.4, pp.239-253	DOI
2018-05	Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells Min, Ahrum; Kim, Jung Eun; Kim, Yu-Jin; Lim, Jee Min; Kim, Seongyeong; Kim, Jin Won; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Bang, Yung-Jue; Im, Seock-Ah Cancer Letters, Vol.430, pp.123-132	DOI
2018-05	Pre-treatment anxiety is associated with persistent chemotherapy-induced peripheral neuropathy in women treated with neoadjuvant chemotherapy for breast cancer Lee, Kwang-Min; Jung, Dooyoung; Hwang, Heesung; Son, Kyung-Lak; Kim, Tae-Yong; Im, Seock-Ah; Lee, Kyung-Hun; Hahm, Bong-Jin Journal of Psychosomatic Research, Vol.108, pp.14-19	DOI
2018-05	Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine Pivot, Xavier; Im, Seock Ah; Guo, Matthew; Marme, Frederik Breast Cancer, Vol.25 No.3, pp.370-374	DOI
2018-06	Safety and antitumor activity of pembrolizumab in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer Rugo, Hope S.; Delord, Jean-Pierre; Im, Seock-Ah; Ott, Patrick A.; Piha-Paul, Sarina A.; Bedard, Philippe L.; Sachdev, Jasgit; Le Tourneau, Christophe; van Brummelen, Emilie M. J.; Varga, Andrea; Salgado, Roberto; Loi, Sherene; Saraf, Sanatan; Pietrangelo, Dina; Karantza, Vassiliki; Tan, Antoinette R. Clinical Cancer Research, Vol.24 No.12, pp.2804-2811	DOI
2018-07	Change in topoisomerase 1–positive circulating tumor cells affects overall survival in patients with advanced breast cancer after treatment with etirinotecan pegol Rugo, Hope S.; Cortes, Javier; Awada, Ahmad; O'Shaughnessy, Joyce; Twelves, Chris; Im, Seock-Ah; Hannah, Alison; Lu, Lin; Sy, Sherwin; Caygill, Katie; Zajchowski, Deborah A.; Davis, Darren W.; Tagliaferri, Mary; Hoch, Ute; Perez, Edith A. Clinical Cancer Research, Vol.24 No.14, pp.3348-3357	DOI
2018-07	Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial Tripathy, Debu; Im, Seock-Ah; Colleoni, Marco; Franke, Fabio; Bardia, Aditya; Harbeck, Nadia; Hurvitz, Sara A.; Chow, Louis; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Vazquez, Rafael Villanueva; Jung, Kyung Hae; Babu, K. Govind; Wheatley-Price, Paul; De laurentiis, Michelino; Im, Young-Hyuck; Kuemmel, Sherko; El-Saghir, Nagi; Liu, Mei-Ching; Carlson, Gary; Hughes, Gareth; Diaz-Padilla, Ivan; Germa, Caroline; Hirawat, Samit; Lu, Yen-Shen The Lancet Oncology, Vol.19 No.7, pp.904-915	DOI
2018-07	Phase 1 studies of poziotinib, an irreversible pan-her tyrosine kinase inhibitor in patients with advanced solid tumors Kim, Tae Min; Lee, Keun-Wook; Oh, Do-Youn; Lee, Jong-Seok; Im, Seock-Ah; Kim, Dong-Wan; Han, Sae-Won; Kim, Yu Jung; Kim, Tae-You; Kim, Jee Hyun; Han, Hyesun; Kim, Woo Ho; Bang, Yung-Jue Cancer Research and Treatment, Vol.50 No.3, pp.835-842	DOI
2018-08	WEE1 억제제의 항종양 효과와 DNA 손상 반응의 조절에 의한 PARP 억제제의 민감성 강화에 관한 연구 하동현	view file
2018-08	Phase III randomized study of ribociclib and fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: MONALEESA-3 Slamon, Dennis J.; Neven, Patrick; Chia, Stephen; Fasching, Peter A.; De Laurentiis, Michelino; Im, Seock-Ah; Petrakova, Katarina; Bianchi, Giulia Val; Esteva, Francisco J.; Martin, Miguel; Nusch, Arnd; Sonke, Gabe S.; De la Cruz-Merino, Luis; Beck, J. Thaddeus; Pivot, Xavier; Vidam, Gena; Wang, Yingbo; Lorenc, Karen Rodriguez; Miller, Michelle; Taran, Tetiana; Jerusalem, Guy Journal of Clinical Oncology, Vol.36 No.24, pp.2465-2472	DOI
2018-08	A first-in-human study of the new oral selective estrogen receptor degrader AZD9496 for ER+/HER2- advanced breast cancer Hamilton, Erika P.; Patel, Manish R.; Armstrong, Anne C.; Baird, Richard D.; Jhaveri, Komal; Hoch, Matthias; Klinowska, Teresa; Lindemann, Justin P. O.; Morgan, Shethah R.; Schiavon, Gaia; Weir, Hazel M.; Im, Seock-Ah Clinical Cancer Research, Vol.24 No.15, pp.3510-3518	DOI
2018-09	Palbociclib plus endocrine therapy in older women with HR+/HER2- advanced breast cancer: A pooled analysis of randomised PALOMA clinical studies Rugo, Hope S.; Turner, Nicholas C.; Finn, Richard S.; Joy, Anil A.; Verma, Sunil; Harbeck, Nadia; Masuda, Norikazu; Im, Seock-Ah; Huang, Xin; Kim, Sindy; Sun, Wan; Iyer, Shrividya; Schnell, Patrick; Bartlett, Cynthia Huang; Johnston, Stephen European Journal of Cancer, Vol.101, pp.123-133	DOI
2018-10	Oncologic safety of gonadotropin-releasing hormone agonist for ovarian function protection during breast cancer chemotherapy Kim, Hee Jeong; Lee, Moo Hyun; Lee, Jeong Eon; Park, Seho; Lee, Eun Sook; Kang, Yong Joon; Shin, Hae Na; Kim, Seung Il; Lee, Jun Ho; Im, Seock Ah; Ahn, Sei Hyun; Lee, Keun Seok; Sohn, Joohyuk; Kim, Seonok; Nam, Seok Jin; Han, Wonshik Clinical Breast Cancer, Vol.18 No.5, pp.e1165-e1172	DOI
2018-11	Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3 Cristofanilli, Massimo; DeMichele, Angela; Giorgetti, Carla; Turner, Nicholas C.; Slamon, Dennis J.; Im, Seock-Ah; Masuda, Norikazu; Verma, Shailendra; Loi, Sherene; Colleoni, Marco; Theall, Kathy Puyana; Huang, Xin; Liu, Yuan; Bartlett, Cynthia Huang European Journal of Cancer, Vol.104, pp.21-31	DOI
2018-11	Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer Schmid, P.; Adams, S.; Rugo, H. S.; Schneeweiss, A.; Barrios, C. H.; Iwata, H.; Dieras, V.; Hegg, R.; Im, S. -A.; Wright, G. Shaw; Henschel, V.; Molinero, L.; Chui, S. Y.; Funke, R.; Husain, A.; Winer, E. P.; Loi, S.; Emens, L. A. New England Journal of Medicine, Vol.379 No.22, pp.2108-2121	DOI
2018-11	Overall survival with palbociclib and fulvestrant in advanced breast cancer Turner, Nicholas C.; Slamon, Dennis J.; Ro, Jungsil; Bondarenko, Igor; Im, Seock-Ah; Masuda, Norikazu; Colleoni, Marco; DeMichele, Angela; Loi, Sherene; Verma, Sunil; Iwata, Hiroji; Harbeck, Nadia; Loibl, Sibylle; Andre, Fabrice; Theall, K. Puyana; Huang, Xin; Giorgetti, Carla; Bartlett, C. Huang; Cristofanilli, Massimo New England Journal of Medicine, Vol.379 No.20, pp.1926-1936	DOI
2018-11	Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2 Campone, Mario; Im, Seock-Ah; Iwata, Hiroji; Clemons, Mark; Ito, Yoshinori; Awada, Ahmad; Chia, Stephen; Jagiello-Gruszfeld, Agnieszka; Pistilli, Barbara; Tseng, Ling-Ming; Hurvitz, Sara; Masuda, Norikazu; Cortes, Javier; De Laurentiis, Michele; Arteaga, Carlos L.; Jiang, Zefei; Jonat, Walter; Le Mouhaer, Sylvie; Sankaran, Banu; Bourdeau, Laurence; El-Hashimy, Mona; Sellami, Dalila; Baselga, Jose European Journal of Cancer, Vol.103, pp.147-154	DOI
2018-11	Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre, open-label, three-arm, randomised phase II trial (FLAG study) Kim, Ji-Yeon; Im, Seock-Ah; Jung, Kyung Hae; Ro, Jungsil; Sohn, Joohyuk; Kim, Jee Hyun; Park, Yeon Hee; Kim, Tae-Yong; Kim, Sung-Bae; Lee, Keun Seok; Kim, Gun Min; Kim, Se Hyun; Kim, Seonwoo; Ahn, Jin Seok; Lee, Kyung-Hun; Ahn, Jin-Hee; Park, In Hae; Im, Young-Hyuck European Journal of Cancer, Vol.103, pp.127-136	DOI
2018-12	nCirculating biomarkers and resistance to endocrine therapy in metastatic breast cancers: Correlative results from AZD9496 oral SERD phase I trial Paoletti, Costanza; Schiavon, Gaia; Dolce, Emily M.; Darga, Elizabeth P.; Carr, T. Hedley; Geradts, Joseph; Hoch, Matthias; Klinowska, Teresa; Lindemann, Justin; Marshall, Gayle; Morgan, Shethah; Patel, Parul; Rowlands, Vicky; Sathiyayogan, Nitharsan; Aung, Kimberly; Hamilton, Erika; Patel, Manish; Armstrong, Anne; Jhaveri, Komal; Im, Seock-Ah; Iqbal, Nadia; Butt, Fouziah; Dive, Caroline; Harrington, Elizabeth A.; Barrett, J. Carl; Baird, Richard; Hayes, Daniel F. Clinical Cancer Research, Vol.24 No.23, pp.5860-5872	DOI
2018-12	A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial Park, Yeon Hee; Lee, Kyung-Hun; Sohn, Joo Hyuk; Lee, Keun Seok; Jung, Kyung Hae; Kim, Jee-Hyun; Lee, Ki Hyeong; Ahn, Jin Seok; Kim, Tae-Yong; Kim, Gun Min; Park, In Hae; Kim, Sung-Bae; Kim, Se Hyun; Han, Hye Sook; Im, Young-Hyuck; Ahn, Jin-Hee; Kim, Jung-Yong; Kang, Jahoon; Im, Seock-Ah International Journal of Cancer, Vol.143 No.12, pp.3240-3247	DOI
2018-12	Effects of trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-overexpressing breast cancer patients treated with chemotherapy and radiotherapy Jeon, Seung Hyuck; Shin, Kyung Hwan; Kim, Jin Ho; Kim, Kyubo; Kim, In Ah; Lee, Kyung-Hun; Kim, Tae-Yong; Im, Seock-Ah Breast Cancer Research and Treatment, Vol.172 No.3, pp.619-626	DOI
2018-12	Androgen receptor inhibitor enhances the antitumor effect of PARP inhibitor in breast cancer cells by modulating DNA damage response Min, Ahrum; Jang, Hyemin; Kim, Seongyeong; Lee, Kyung-Hun; Kim, Debora Keunyoung; Suh, Koung Jin; Yang, Yaewon; Elvin, Paul; O'Connor, Mark J.; Im, Seock-Ah Molecular Cancer Therapeutics, Vol.17 No.12, pp.2507-2518	DOI
2019-01	Randomized Open Labe Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01) Park, In Hae; Im, Seock-Ah; Jung, Kyung Hae; Sohn, Joo Hyuk; Park, Yeon Hee; Lee, Keun Seok; Sim, Sung Hoon; Park, Kyong-Hwa; Kim, Jee Hyun; Nam, Byung Ho; Kim, Hee-Jun; Kim, Tae-Yong; Lee, Kyung-Hun; Kim, Sung-Bae; Ahn, Jin-Hee; Lee, Suee; Ro, Jungsil Cancer Research and Treatment, Vol.51 No.1, pp.43-52	DOI
2019-01	Landscape of actionable genetic alterations profiled from 1,071 tumor samples in Korean cancer patients Lee, Se-Hoon; Lee, Boram; Shim, Joon Ho; Lee, Kwang Woo; Yun, Jae Won; Kim, Sook-Young; Kim, Tae-You; Kim, Yeul Hong; Ko, Young Hyeh; Chung, Hyun Cheol; Yu, Chang Sik; Lee, Jeeyun; Rha, Sun Young; Kim, Tae Won; Jung, Kyung Hae; Im, Seock-Ah; Moon, Hyeong-Gon; Cho, Sukki; Kang, Jin Hyoung; Kim, Jihun; Kim, Sang Kyum; Ryu, Han Suk; Ha, Sang Yun; Kim, Jong Il; Chung, Yeun-Jun; Kim, Cheolmin; Kim, Hyung-Lae; Park, Woong-Yang; Noh, Dong-Young; Park, Keunchil Cancer Research and Treatment, Vol.51 No.1, pp.211-222	DOI

1 5 6 7 8 9